Inventor · disambiguated record
Christopher Fuller
Also filed as: FULLER CHRISTOPHER · FULLER CHRISTOPHER WILLIAM
9 granted patents·7 pending applications·13 citations·filing 2014–2023
81Inventor score
Top patents by PatentIndex Score
16 records- 0188US11185497B2Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2020·Granted Nov 30, 2021·2 cites·5 claims
- 0285US11191910B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2019·Granted Dec 7, 2021·5 cites·20 claims
- 0378US2024115819A1In-Line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0475US11266799B2In-line nasal delivery deviceIMPEL NEUROPHARMA INC·Filed 2016·Granted Mar 8, 2022·2 cites·12 claims
- 0575US2023241334A1In-line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0674US11395887B2Intranasal device with inlet interfaceIMPEL PHARMACEUTICALS INC·Filed 2018·Granted Jul 26, 2022·2 cites·13 claims
- 0772US2023095719A1In-line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0871US2024252489A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesWOODWARD SPECIALTY LLC·Filed 2023·Application pending·0 cites
- 0968US2022105030A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1067US11878110B2Intranasal device with inlet interfaceIMPEL PHARMACEUTICALS INC·Filed 2022·Granted Jan 23, 2024·0 cites·18 claims
- 1162US10537692B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2014·Granted Jan 21, 2020·2 cites·20 claims
- 1258US2021236485A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1356US2019209463A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Application pending·0 cites
- 1449US11878109B2Single-use nasal delivery deviceIMPEL PHARMACEUTICALS INC·Filed 2020·Granted Jan 23, 2024·0 cites·20 claims
- 1547US11759585B2Nasal drug delivery device with detachable nozzleIMPEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 19, 2023·0 cites·25 claims
- 1643US11571532B2Intranasal device with dip tubeIMPEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 7, 2023·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Fuller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →